Growth factors, receptors, and molecular alterations in pancreatic cancer. Putting it all together.
Because of the dismal prognosis of advanced ductal pancreatic adenocarcinoma, recent investigational strategies have focused on improved detection and therapeutic intervention in early-stage pancreatic cancer. The obvious cost constraints of screening populations at risk but with a low tumor yield will restrict screening protocols to only the highest risk groups (hereditary pancreatitis = age 50, certain hereditary pancreatic cancer kindreds). The vast majority of patients, either lacking or exhibiting an inherited predisposition to pancreatic cancer, will continue to present with disease not resectable for cure. The authors believe that the best hope for these patients lies in the further delineation of the integrative pathophysiology driving tumor growth; this would facilitate the future development of a computer program or other modality that would predict the dominant pathways driving the growth and spread of each tumor based on its "molecular profile." This article reviews the authors' current knowledge regarding the growth factors, receptors, and molecular alterations driving uncontrolled proliferation, local invasion, and metastatic spread of these tumors. The current and potential contributions of studies in cohorts with an inherited predisposition to pancreatic cancer to this pathophysiologic model are also discussed. The future strategy for incorporating this information into a working pathophysiologic road map with clinical relevance is subsequently outlined.
Ulrich
C D
CD
Department of Internal Medicine, University of Cincinnati, Ohio, USA.
D000230:Adenocarcinoma / Q000235:genetics*; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D002869:Chromosome Aberrations / Q000235:genetics*; D005820:Genetic Testing; D006133:Growth Substances / Q000235:genetics*; D006801:Humans; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000235:genetics*; D010195:Pancreatitis / Q000235:genetics; D011230:Precancerous Conditions / Q000235:genetics; D011379:Prognosis; D017978:Receptors, Growth Factor / Q000235:genetics*
D006133:Growth Substances; D017978:Receptors, Growth Factor